Bioxytran (BIXT) Registration Filing summary

Offering details and pricing

• Registration covers up to 18,000,000 shares of Common Stock to be issued in an indirect primary offering to TRITON FUNDS LP pursuant to a Closing Agreement.

• The offering will commence as soon as practicable after the registration statement is declared effective.

Underwriters and syndicate

• TRITON FUNDS LP is identified as the recipient of the shares in the offering.

Management team and governance

• The registration statement is signed by the President & CEO, Chief Financial Officer, and all directors, with David Platt, Ph.D. serving as President, CEO, and Chairman.

• Power of attorney is granted to David Platt, Ola Soderquist, and Robert J. Burnett for filing and compliance matters.